Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial
Titel:
Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial
Auteur:
Gore, Martin E Griffin, Clare L Hancock, Barry Patel, Poulam M Pyle, Lynda Aitchison, Michael James, Nicholas Oliver, Roderick TD Mardiak, Jozef Hussain, Tahera Sylvester, Richard Parmar, Mahesh KB Royston, Patrick Mulders, Peter FA